Skip to content

QuidelOrtho Corporation QDEL Allowance for doubtful accounts

Allowance for doubtful accounts at other companies

Abbott logo
AbbottABT
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
Danaher logo
DanaherDHR
Charles River Laboratories logo
Charles River LaboratoriesCRL
Butterfly Network logo
Butterfly NetworkBFLY
Haemonetics logo
HaemoneticsHAE

Other financials

Income statement

See full
Revenue$619.8M-10.5%
Gross profit$263.8M-23.2%
Operating income-$31.8M-198%
Net income-$91.8M-623%
EPS (diluted)-$1.35-611%

Balance sheet

See full
Cash & equivalents$140.4M+10.4%
Total debt$3.1B+0.3%
Total equity$1.9B-38.2%
Total assets$5.6B-12.9%

Cash flow

See full
Operating cash flow-$33.0M-150%
CapEx$34.0M-39.5%
Free cash flow-$67.0M-813%

Valuation

See full
Market cap$921.94M-51.4%
Enterprise value$3.88B-20.1%
P/S0.4×-0.3×

Profitability

See full
Gross margin45%-2.0pp
Operating margin-37%-46.2pp
Net margin-45.6%-75.7pp
FCF margin13.8%

Returns & leverage

See full
Return on equity-49.9%-70.8pp
Debt / equity1.7×+0.6×
Current ratio1.4×+0.2×

Where this comes from

Reported directly by QuidelOrtho Corporation in its filing.

Tagged under the XBRL concept us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent.

The official record: QuidelOrtho Corporation’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about QuidelOrtho Corporation's allowance for doubtful accounts.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is QuidelOrtho Corporation's allowance for doubtful accounts?
QuidelOrtho Corporation (QDEL) reported allowance for doubtful accounts of $16.7M in Q1 2026.
How has QuidelOrtho Corporation's allowance for doubtful accounts changed year-over-year?
QuidelOrtho Corporation's allowance for doubtful accounts increased by 13.6% year-over-year, from $14.7M to $16.7M.
What is the long-term trend for QuidelOrtho Corporation's allowance for doubtful accounts?
Over 2 years (2023 to 2025), QuidelOrtho Corporation's allowance for doubtful accounts has grown at a 8.9% compound annual growth rate (CAGR), from $14.6M to $17.3M.